(Q42510108)

1 November 2017

Chronic desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens (English)

1 reference

1 November 2017

0 references

1 reference

Pallis E

1

1 reference

1 November 2017

Thermos K

series ordinal

2

1 reference

1 November 2017

Spyraki C

series ordinal

3

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

European Journal of Neuroscience

1 November 2017

1 reference

1 November 2017

14

1 reference

1 November 2017

4

1 reference

1 November 2017

763-767

1 reference

Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat.

1 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Effect of morphine applied by intrapallidal microdialysis on the release of dopamine in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Somatostatin in the central nervous system: physiology and pathological modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Effects of acute and chronic desipramine treatment on somatostatin receptors in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Evidence that somatostatin sst2 receptors mediate striatal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Striatal interneurones: chemical, physiological and morphological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger rna levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Dopamine-somatostatin interactions in the rat striatum: an in vivo microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: A light and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01698.X

10.1046/J.0953-816X.2001.01698.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference